TickerFacts.

Biovie Inc. (BIVI): Net Income

Annual figures by period end, from SEC filings.

-$22.07M
Year ended 2026-06-30
2013-06-30: -$17.5K2014-06-30: -$321.9K2015-06-30: -$233.0K2016-06-30: -$431.9K2017-06-30: -$1.33M2018-06-30: -$2.43M2020-06-30: -$16.68M2021-06-30: -$130.25M2022-06-30: -$26.08M2023-06-30: -$50.26M2024-06-30: -$32.12M2025-06-30: -$17.54M2026-06-30: -$22.07M-$22.07M
2013-06-30 Net Income (USD) 2026-06-30
Period endedNet IncomeChange YoYSource filing
2026-06-30-$22.07Mn/m2026-08-13, From 2025-07-01
2025-06-30-$17.54Mn/m2026-08-13, From 2024-07-01
2024-06-30-$32.12Mn/m2025-08-15, From 2023-07-01
2023-06-30-$50.26Mn/m2024-09-30, From 2022-07-01
2022-06-30-$26.08Mn/m2023-08-16, From 2021-07-01
2021-06-30-$130.25Mn/m2022-09-27, From 2020-07-01
2020-06-30-$16.68Mn/a2021-08-30, From 2019-07-01
No annual figure between 2018-06-30 and 2020-06-30.
2018-06-30-$2.43Mn/m2018-10-05, From 2017-07-01
2017-06-30-$1.33Mn/m2018-10-05, From 2016-07-01
2016-06-30-$431.9Kn/m2017-08-24, From 2015-07-01
2015-06-30-$233.0Kn/m2016-09-28, From 2014-07-01
2014-06-30-$321.9Kn/m2015-10-01, From 2013-07-01
2013-06-30-$17.5Kn/a2014-09-24, From 2012-07-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Biovie Inc. (BIVI)2026-06-30-$22.07Mn/m
Exicure, Inc. (XCUR)2025-12-31-$4.95Mn/m
Actuate Therapeutics, Inc. (ACTU)2025-12-31-$22.23Mn/m
CytoDyn Inc. (CYDY)2026-05-31-$42.70Mn/m
Chemomab Therapeutics Ltd. (CMMB)2025-12-31-$8.99Mn/m
CalciMedica, Inc. (CALC)2025-12-31-$29.56Mn/m
Cellectar Biosciences, Inc. (CLRB)2025-12-31-$21.79Mn/m
Edesa Biotech, Inc. (EDSA)2025-09-30-$7.19Mn/m
Cingulate Inc. (CING)2025-12-31-$22.45Mn/m

Compare BIVI, XCUR, ACTU, CYDY side by side · Screen every company in Pharmaceutical Preparations ↗